Literature DB >> 7732971

Intracoronary ultrasound imaging before and after directional coronary atherectomy: in vitro and clinical observations.

S Nakamura1, D J Mahon, C Y Leung, B Maheswaran, D E Gutfinger, J Yang, R Zelman, J M Tobis.   

Abstract

The rate of restenosis after directional coronary atherectomy (DCA) is higher than expected. To elucidate why, the current study used intravascular ultrasound (IVUS) imaging to investigate the mechanism of DCA. An in vitro validation study was performed to determine the accuracy of the measurement of plaque removal by IVUS. DCA was performed in eight human atherosclerotic artery segments. The volume of removed plaque was measured by water displacement and was compared with the volume calculated from IVUS images. A clinical study of DCA was performed in 32 lesions. IVUS was performed in 28 lesions after successful DCA. Measurements of lumen dimensions from digital angiograms before and after DCA were compared with observations of lumen and plaque size from the cross-sectional IVUS images. In the in vitro study, the mean plaque volume removed by DCA was 19.9 +/- 8.5 microliters. The calculated estimate of removed plaque volume by IVUS was 18.6 +/- 7.9 microliters and correlated closely with the volume by water displacement (r = 0.92). The calculated volume of plaque removed from histologic sections was 14.3 +/- 6.0 microliters and was linearly correlated with plaque volume by water displacement (r = 0.81). In the clinical study, the angiographic mean minimum lumen diameter increased from 1.0 +/- 0.4 to 2.7 +/- 0.5 mm and the percentage stenosis decreased from 70% to 19% (p < 0.0001). The IVUS images before and after DCA showed that the lumen DCA improved from 2.9 +/- 1.5 to 7.0 +/- 1.5 mm2 (p < 0.0001). In addition the vessel cross-sectional area (CSA) increased from 17.1 +/- 5.9 to 18.7 +/- 5.5 mm2. The atheroma CSA was reduced from 14.2 +/- 5.0 to 11.7 +/- 4.8 mm2. This combined effect of reduction in atheroma CSA and stretching of the outer vessel diameter resulted in an improvement in percentage plaque area stenosis from 83% +/- 7% to 61% +/- 9%. It is concluded that despite a successful angiographic appearance, DCA removed an average of 2.5 mm2 from the atheroma, which corresponds to only 18% of the atheroma CSA. The total lumen CSA increased 4.1 mm2; 61% of the new lumen was created by cutting and removal of plaque, whereas 39% of the new lumen was made by stretching the external wall of the artery. Despite an excellent angiographic result, IVUS imaging reveals that after DCA a significant amount of residual atheroma remains. As in balloon dilatation, a stretching effect is a significant component of DCA.

Entities:  

Mesh:

Year:  1995        PMID: 7732971     DOI: 10.1016/0002-8703(95)90102-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

1.  If directional coronary atherectomy is useful then why is it not used more often?

Authors:  M Khan
Journal:  Heart       Date:  1997-10       Impact factor: 5.994

Review 2.  Advanced imaging in limb salvage.

Authors:  Cassidy Duran; Jean Bismuth
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Oct-Dec

3.  Preintervention lesion remodelling affects operative mechanisms of balloon optimised directional coronary atherectomy procedures: a volumetric study with three dimensional intravascular ultrasound.

Authors:  C von Birgelen; G S Mintz; E A de Vrey; P W Serruys; T Kimura; M Nobuyoshi; J J Popma; M B Leon; R Erbel; P J de Feyter
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

4.  Vascular Response after Directional Coronary Atherectomy for Left Main Bifurcation Lesion.

Authors:  Norihiro Kobayashi; Masahiro Yamawaki; Mana Hiraishi; Shinsuke Mori; Masakazu Tsutsumi; Yohsuke Honda; Toshiki Chishiki; Kenji Makino; Shigemitsu Shirai; Masafumi Mizusawa; Kohei Yamaguchi; Takahide Nakano; Kaori Abe; Tomoya Fukagawa; Toshihiko Kishida; Yoshiaki Ito
Journal:  J Interv Cardiol       Date:  2021-12-14       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.